According to the most recent filing that One Wealth Advisors LLC made with the Securities and Exchange Commission (SEC), the company increased its holdings in Enovix Co (NASDAQ: ENVX) during the third quarter of this year.
The institutional investor purchased 75,000 shares of the company’s stock for approximately $1,375,000.
As a direct consequence of this, the proportional holdings of ENVX by various hedge funds have also been subject to modification. Quantbot Technologies LP increased its stake in Enovix by increasing its shareholding in the company during the second quarter by purchasing approximately $26,000 worth of shares. Sierra Capital LLC shelled out approximately $47,000 during the second quarter to acquire a new position in Enovix. HBK Source Advisory LLC spent approximately $48,000 to acquire a new stake in Enovix during the third quarter of the fiscal year. Zurcher Kantonalbank is a Swiss bank.
During the second quarter, Zurich Cantonalbank made additional investments in Enovix, bringing the company’s commitment to approximately $61,000.
During the third quarter, Emerald Advisers LLC also purchased a new interest in Enovix valued at approximately $62,000.
This acquisition took place. Shares of the company are currently owned by hedge funds and other types of institutional investors, who collectively hold 55.62% of the total.
Several different brokerages have offered their thoughts on ENVX. Craig Hallum lowered their price objective on Enovix stock from $23.00 to $15.00 and changed their “buy” rating for the company from “hold” to “buy” in a research note that was published on Thursday.
In a research note dated January 4, B. Riley announced that their price goal for Enovix shares had been reduced from $19.00 to $18.00.
In a research report released on Thursday, January 26, JPMorgan Chase & Co lowered their price target on Enovix shares from $28.00 to $16.00, giving the company an “overweight” rating.
In a research report published on November 2, Cowen announced that they would lower their price target on Enovix stock from $36.00 to $25.00. Canaccord Genuity Group finally began providing coverage for Enovix shares in a research note issued on January 11 and available to the public.
They recommended purchasing the stock and setting a target price of $20.00.
According to the information provided by Bloomberg, the recommendation to purchase the stock was made by twelve different research specialists.
The current rating for Enovix is “buy,” which is the standard in this sector, and the company has set a price target of $27.92.
On January 3, 2019, CTO Ashok Lahiri made a transaction to sell 2,000 shares of Enovix stock.
This was covered in a report that was published on its own.
A total of 25,620.00 dollars’ worth of the company’s stock was traded for $12.81 per share, making the trades 25,620.00 dollars.
There are currently 1,358,265 shares of the company’s stock that the company’s Chief Technology Officer directly holds.
These shares have a total value of approximately $17,399,374.65.
If you click on this link, you will be taken to the filing submitted to the Securities and Exchange Commission and where the transaction was discussed. Recently, company insiders parted ways with 5,481 shares, realizing a combined profit of $63,687.
The company’s management and employees own 20.60 percent of the total shares.
As of noon on Friday, the price of a share of ENVX had dropped by $0.57, bringing it to $8.70.
The total number of shares of the company’s stock that changed hands was 2,372,940, significantly lower than its average volume of 4,961,278 shares.
Enovix Company hit an all-time low of $6.50 during the past year, while it reached an all-time high of $26.30 during the same period.
The price of one share of stock is $9.12 according to its simple moving average over the past 50 days, and the price of one stock is $14.37 according to its simple moving average over the past 200 days.
The Enovix Corporation is the developer and designer of lithium-ion batteries and manufacturer of lithium-ion batteries.
The company was established in 2007 and can be found in Fremont, which is in California.